Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia
Phase 2
90
about 3.3 years
18–55
Female only
2 sites in MA
Why this study is shown
What this study is about
Researchers are testing whether eplerenone, a medication, improves coronary microvascular function better than chlorthalidone in women who had preeclampsia. The trial will last 1215 days and involve taking either eplerenone + potassium or chlorthalidone + potassium daily for 48 weeks.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Chlorthalidone 25 mg daily
- 2.Take Eplerenone 100 mg daily
- 3.Take Potassium Chloride
- +1 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
chlortalidone, eplerenone, potassium chloride
oral (Oral Tablet)
Cardiology / Heart